Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Executive Summary
The Global Endoscopes or endoscopy devices market is projected to display a significant growth represented by a CAGR of 6.50% during 2021 - 2026. The global Endoscopes market was valued at USD 10.97 billion in the year 2020 with North America region leading the regional market share. Increasing preference for minimally invasive surgeries, rising prevalence of chronic diseases (cancer, heart diseases, gastrointestinal diseases ), aging population, increasing healthcare expenditure and introduction of new endoscopic products are the major factors that are expected to boost the demand of endoscopes in the region. Meanwhile, the demand in developed economies is already really high and the future growth is going to remain quite significant.
However, the Asia Pacific region is expected to witness lucrative growth over the forecast period owing to high demand for endoscopic procedures along with improving healthcare infrastructure that will drive the market for Endoscopes in the forthcoming years. Intense competition among endoscopes makers exists due to the increasing demand for endoscopes for various diagnostic and therapeutic procedures, coupled with technological advances. Increasing market demand is likely to encourage entry of new companies in the future, driven by the increasing awareness and acceptance of endoscopes and related technologies.
The COVID-19 is an incomparable global public health emergency that has affected almost every industry, including the endoscopes, non-urgent surgical care and other healthcare industries in multiple ways. The COVID-19 episode has disrupted the market of Endoscopes in different nations because of lockdowns, travel boycotts, and implementation of stay-at-home orders. The highly infectious nature, hospitalization and mortality rates associated with COVID-19 has impacted clinical care for many life-threatening conditions and has quite naturally postponed many non-urgent surgical or endoscopic procedures in order to minimize the risk of infection and to compliance with various governmental orders. As, the healthcare resources, including the surgical and endoscopy centers were deviated towards Covid care.
Rising prevalence of chronic diseases, increasing adoption of endoscopes for treatment and diagnosis, and technological advancements leading to enhanced applications of endoscopes. Furthermore, the growing preference for minimally-invasive surgeries over traditional/open surgeries are driving the utilization of various endoscopic procedures for diagnosis, such as gastrointestinal endoscopy, laparoscopy, arthroscopy, cystoscopy etc. These factors, in turn, are projected to fuel the demand for Endoscopes over the coming years.
One of the global leaders in medical devices industry, Olympus Corporation has focused on endoscopes innovation and some strategic M&A activity. For instance, in 2020, the company announced their U.S. FDA approved new and most advanced endoscopy system EVIS X1, it will improve outcomes from disorders of the stomach, colon, and oesophagus, as well as from bronchial diseases, by providing every endoscopists with innovative and proven tools worldwide. Alongside, in 2021, the company acquired Quest Photonic Devices B.V. (Netherlands) to strengthen its surgical endoscope business and add abdominal surgical instruments to its portfolio.
Scope of the Report
• The report presents the analysis of Endoscopes Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses the Endoscopes Market by value (USD Millions).
• The report analyses the Endoscopes Market by Product Type (Flexible Endoscopes, Rigid Endoscopes, Others).
• The report analyses the Endoscopes Market by Application (GI endoscopy, Laparoscopy, Arthroscopy, Others)
• The report analyses the Endoscopes Market by End User (Hospitals, Ambulatory Surgical Centers, Others)
• The Global Endoscopes Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA).
• The Global Endoscopes Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, India, Australia).
• The key insights of the report have been presented through the frameworks of SWOT Analysis and Porter Five Force Analysis. Also, the attractiveness of the market has been presented by region, by Product Type, by Application and by End User.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product developments. The companies analysed in the report include Olympus, Johnson & Johnson, Boston Scientific, Stryker Corporation, ConMed Corporation, Hoya Corporation, Medtronic, Steris Corporation, Fujifilm, Karl Storz SE.
Key Target Audience
• Endoscopes products or Endoscopy devices Manufacturers
• Pharmaceutical Industry
• Biotechnology Companies
• Government and Research Organisations
• Consulting and Advisory Firms
• Investment Banks and Equity Firms
List of Figures
Figure 1: Global Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 3: Global Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 4: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2014-2018 (In %)
Figure 5: Prevalence of Gastroesophageal Reflux Disease, By Region, 2018 (In %)
Figure 6: Prevalence of GERD and Estimated Population in United States and EU 5
Figure 7: Global Aged Population (Above 65), 2015-20 (% of total Population)
Figure 8: Global Aged Population (Above 65), By Country, 2020 (% of total Population)
Figure 9: Global Endoscopes Market- By Product Type Market Share, 2020 & 2026
Figure 10: Global Endoscopes Market- By Flexible Endoscopes, By Value (USD Million), 2016-2026
Figure 11: Global Endoscopes Market- By Rigid Endoscopes, By Value (USD Million), 2016-2026
Figure 12: Global Endoscopes Market- By Others, By Value (USD Million), 2016-2026
Figure 13: Global Endoscopes Market - By Application Market Share, 2020 & 2026
Figure 14: Global Endoscopes Market- By GI Endoscopy, By Value (USD Million), 2016-2026
Figure 15: Global Endoscopes Market- By Rigid Endoscopes, By Value (USD Million), 2016-2026
Figure 16: Global Endoscopes Market- By Arthroscopy, By Value (USD Million), 2016-2026
Figure 17: Global Endoscopes Market- By Others, By Value (USD Million), 2016-2026
Figure 18: Global Endoscopes Market- By End User Market Share, 2020 & 2026
Figure 19: Global Endoscopes Market- By Hospitals, By Value (USD Million), 2016-2026
Figure 20: Global Endoscopes Market- By Ambulatory Surgery Centers, By Value (USD Million), 2016-2026
Figure 21: Global Endoscopes Market- By Others, By Value (USD Million), 2016-2026
Figure 22: Global Endoscopes Market- By Region Market Share, 2020 & 2026
Figure 23: North America Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 24: North America estimated number of Cancer incidences & prevalent cases (all ages, in thousand's), Year 2020
Figure 25: North America Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 26: North America Current health expenditure per capita (current USD), 2014-18
Figure 27: North America Population ages 65 and above (% of total Population), 2016-20
Figure 28: North America Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 29: North America Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 30: North America Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 31: Market Opportunity Chart of North America Endoscopes Market- By Country, By Value (Year-2026)
Figure 32: North America Endoscopes Market- By Country Market Share, 2020 & 2026
Figure 33: United States Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 34: United States Current health expenditure per capita (current USD), 2014-18
Figure 35: United States Population aged 65 and above (% of total Population), 2016-20
Figure 36: Percent of adults aged 18+ with obesity Crude Prevalence in the U.S., 2014-218
Figure 37: Cancer Prevalence in United States, 2020
Figure 38: United States Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 39: United States Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 40: United States Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 41: Canada Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 42: Canada Current health expenditure per capita (current USD), 2014-18
Figure 43: Canada Population aged 65 and above (% of total Population), 2016-20
Figure 44: Estimated number of deaths by cancer in Canada, 2020
Figure 45: Estimated number of Cancer Prevalent cases in Canada, 2020
Figure 46: Canada Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 47: Canada Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 48: Canada Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 49: Europe Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 50: Europe Current health expenditure per capita (current USD), 2014-18
Figure 51: Europe Population ages 65 and above (% of total Population), 2016-20
Figure 52: Population ages 65 and above (% of total Population) in European Countries, 2020
Figure 53: Europe estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 54: Europe Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 55: Europe Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 56: Europe Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 57: Market Opportunity Chart of Europe Endoscopes Market- By Country, By Value (Year-2026)
Figure 58: Europe Endoscopes Market- By Country Market Share, 2020 & 2026
Figure 59: Germany Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 60: Germany Healthcare Industry Scenario (2016-2019)
Figure 61: Germany, Estimated percentage of prevalent Cancer cases, 2020
Figure 62: Germany, Population ages 65 and above (% total), 2016-2020
Figure 63: Germany Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 64: Germany Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 65: Germany Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 66: United Kingdom Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 67: United Kingdom Current health expenditure per capita, PPP (current int. USD), 2014-18
Figure 68: United Kingdom Population ages 65 and above (% of total Population), 2016-20
Figure 69: United Kingdom, Estimated percentage of prevalent Cancer cases, 2020
Figure 70: United Kingdom, estimated number of deaths from different cancers (in 1000ís), 2020
Figure 71: United Kingdom Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 72: United Kingdom Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 73: United Kingdom Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 74: France Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 75: France Current health expenditure per capita (current USD), 2014-18
Figure 76: France, Population ages 65 and above (% of total Population), 2016-20
Figure 77: France, Estimated percentage of prevalent Cancer cases, 2020
Figure 78: France, estimated number of deaths from different cancers (in 1000ís), 2020
Figure 79: France Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 80: France Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 81: France Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 82: Italy Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 83: Italy Current health expenditure per capita (current USD), 2014-18
Figure 84: Italy Population ages 65 and above (% of total Population), 2016-20
Figure 85: Italy, Estimated percentage of prevalent Cancer cases, 2020
Figure 86: Italy, estimated number of deaths from different cancers (in 1000ís), 2020
Figure 87: Italy Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 88: Italy Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 89: Italy Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 90: Asia Pacific Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 91: Asia Pacific, Current health expenditure per capita (current USD), 2014-18
Figure 92: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Figure 93: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2018
Figure 94: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
Figure 95: Asia Pacific estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 96: Asia Pacific, Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 97: Asia Pacific Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 98: Asia Pacific Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 99: Asia Pacific Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 100: Market Opportunity Chart of APAC Endoscopes Market- By Country, By Value (Year-2026)
Figure 101: APAC Endoscopes Market- By Country Market Share, 2020 & 2026
Figure 102: China Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 103: Chinaís Potential Market (Hospitals classified into different classes)
Figure 104: China Current health expenditure per capita (current USD), 2014-18
Figure 105: China Population ages 65 and above (% of total Population), 2016-20
Figure 106: China estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 107: China, Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 108: China Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 109: China Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 110: China Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 111: Japan Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 112: Japan Healthcare Expenditure Outlook (%)
Figure 113: Japan Population ages 65 and above (% of total Population), 2016-20
Figure 114: Japan estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 115: Japan, Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 116: Japan Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 117: Japan Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 118: Japan Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 119: India Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 120: India Current health expenditure per capita (current USD), 2014-18
Figure 121: India Population ages 65 and above (% of total Population), 2016-20
Figure 122: India, estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 123: India, Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 124: India Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 125: India Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 126: India Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 127: Australia Endoscopes Market Size, By Value, 2016-2026 (USD Million)
Figure 128: Australia Current health expenditure per capita (current USD), 2014-18
Figure 129: Australia Population ages 65 and above (% of total Population), 2016-20
Figure 130: Australia estimated number of Cancer incidences and prevalent cases (all ages, in thousand's), Year 2020
Figure 131: Australia, Cancer related number of deaths (all ages, in thousand's), Year 2020
Figure 132: Australia Endoscopes Market- By Product Type, By Value (USD Million), 2016-2026
Figure 133: Australia Endoscopes Market- By Application, By Value (USD Million), 2016-2026
Figure 134: Australia Endoscopes Market- By End User, By Value (USD Million), 2016-2026
Figure 135: Market Attractiveness Chart of Global Endoscopes Market- By Product Type (Year-2026)
Figure 136: Market Attractiveness Chart of Global Endoscopes Market - By Application, By Value (Year 2026)
Figure 137: Market Attractiveness Chart of Global Endoscopes Market- By End User (Year-2026)
Figure 138: Market Attractiveness Chart of Global Endoscopes Market- By Region (Year-2026)
Figure 139: Global Gastrointestinal Endoscopes company market share (%), 2020
Figure 140: Global Surgical Endoscopes company market share (%), 2020
Figure 141: Global Energy Devices company market share (%), 2020
Figure 142: Olympus Corporation Annual Sales Revenue, 2016-2020 (USD Million)
Figure 143: Olympus Corporation Net Income, 2016-2020 (USD Million)
Figure 144: Olympus Corporation Sales Revenue, By Business Segment (%), FY2020
Figure 145: Olympus Corporation Sales Revenue, By Geographical Segment (%), FY2020
Figure 146: J & J Annual Sales Revenue, 2016-2020 (USD Million)
Figure 147: J & J Net Income, 2016-2020 (USD Million)
Figure 148: J & J Sales Revenue, By Business Segment (%), FY2020
Figure 149: J & J Sales Revenue, By Geographical Segment (%), FY2020
Figure 150: ConMed Corporation Annual Sales Revenue, 2016-2020 (USD Million)
Figure 151: ConMed Corporation Net Income, 2016-2020 (USD Million)
Figure 152: ConMed Corporation Sales Revenue, By Business Segment (%), FY2020
Figure 153: ConMed Corporation Sales Revenue, By Geographical Segment (%), FY2020
Figure 154: Stryker Corporation Annual Sales Revenue, 2016-2020 (USD Million)
Figure 155: Stryker Corporation Net Income, 2016-2020 (USD Million)
Figure 156: Stryker Corporation Sales Revenue, By Business Segment (%), FY2020
Figure 157: Stryker Corporation Sales Revenue, By Geographical Segment (%), FY2020
Figure 158: Hoya Corporation Annual Sales Revenue, 2016-2020 (USD Million)
Figure 159: Hoya Corporation Gross Profit, 2016-2020 (USD Million)
Figure 160: Hoya Corporation Sales Revenue, By Business Segment (%), FY2020
Figure 161: Hoya Corporation Sales Revenue, By Geographical Segment (%), FY2020
Figure 162: Boston Scientific Annual Sales Revenue, 2016-2020 (USD Million)
Figure 163: Boston Scientific Net Income, 2016-2020 (USD Million)
Figure 164: Boston Scientific Sales Revenue, By Business Segment (%), FY2020
Figure 165: Boston Scientific Sales Revenue, By Geographical Segment (%), FY2020
Figure 166: Medtronic Annual Sales Revenue, 2016-2020 (USD Million)
Figure 167: Medtronic Net Income, 2016-2020 (USD Million)
Figure 168: Medtronic Sales Revenue, By Business Segment (%), FY2020
Figure 169: Medtronic Sales Revenue, By Geographical Segment (%), FY2020
Figure 160: Steris Annual Sales Revenue, 2016-2020 (USD Million)
Figure 171: Steris Net Income, 2016-2020 (USD Million)
Figure 172: Steris Sales Revenue, By Business Segment (%), FY2020
Figure 173: Steris Sales Revenue, By Geographical Segment (%), FY2020
Figure 174: Fujifilm Annual Sales Revenue, 2016-2020 (USD Million)
Figure 175: Fujifilm Net Income, 2016-2020 (USD Million)
Figure 176: Fujifilm Sales Revenue, By Business Segment (%), FY2020
Figure 177: Fujifilm Sales Revenue, By Geographical Segment (%), FY2020
| Price : US$ 3,500 |
Date : Jun 2023 |
| Category : Services |
Pages : 158 |
| Price : US$ 3,500 |
Date : Jun 2023 |
| Category : Services |
Pages : 158 |
Request Sample 
Request Discount 
Inquire Before Buy
